AR038390A1 - Proceso para preparar propionato de fluticasona. - Google Patents
Proceso para preparar propionato de fluticasona.Info
- Publication number
- AR038390A1 AR038390A1 ARP030100299A ARP030100299A AR038390A1 AR 038390 A1 AR038390 A1 AR 038390A1 AR P030100299 A ARP030100299 A AR P030100299A AR P030100299 A ARP030100299 A AR P030100299A AR 038390 A1 AR038390 A1 AR 038390A1
- Authority
- AR
- Argentina
- Prior art keywords
- fluticasone propionate
- organic phase
- phase
- solvating
- optionally
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Reivindicación 4: Un proceso para preparar propionato de fluticasona en la forma polimórfica cristalina 1 , que comprende : (a) hacer reaccionar un compuesto de fórmula (1) o una sal del mismo con un compuesto de fórmula LCH2F, en la que L representa un grupo saliente, opcionalmente en presencia de un catalizador de transferencia de fases, un disolvente líquido orgánico no solvatante inmiscible con agua y agua; (b) aumentar opcionalmente la pureza del propionato de fluticasona en la fase orgánica realizando una o más etapas de lavado acuoso; (c) separar la fase orgánica de la fase acuosa y concentrar opcionalmente el propionato de fluticasona en la fase orgánica; (d) mezclar la solución de propionato de fluticasona en el disolvente líquido orgánico no solvatante, inmiscible con agua presente en la fase orgánica con un antidisolvente líquido orgánico no solvatante causando así que el propionato de fluticasona cristalice de la solución en la forma polimórfica cristalina 1.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0202564.1A GB0202564D0 (en) | 2002-02-04 | 2002-02-04 | Process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR038390A1 true AR038390A1 (es) | 2005-01-12 |
Family
ID=9930366
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030100299A AR038390A1 (es) | 2002-02-04 | 2003-01-31 | Proceso para preparar propionato de fluticasona. |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20050222107A1 (es) |
| EP (1) | EP1474436B1 (es) |
| JP (1) | JP2005517019A (es) |
| KR (1) | KR20040086331A (es) |
| CN (1) | CN100338087C (es) |
| AR (1) | AR038390A1 (es) |
| AT (1) | ATE446965T1 (es) |
| AU (1) | AU2003206836B2 (es) |
| BR (1) | BR0307243A (es) |
| CA (1) | CA2473896A1 (es) |
| CO (1) | CO5611115A2 (es) |
| DE (1) | DE60329824D1 (es) |
| GB (1) | GB0202564D0 (es) |
| IS (1) | IS7373A (es) |
| MX (1) | MXPA04007530A (es) |
| NO (1) | NO327138B1 (es) |
| NZ (1) | NZ534320A (es) |
| PL (1) | PL372214A1 (es) |
| RU (1) | RU2333218C2 (es) |
| TW (1) | TW200410982A (es) |
| WO (1) | WO2003066653A2 (es) |
| ZA (1) | ZA200405826B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL153462A0 (en) * | 2002-12-16 | 2003-07-06 | Chemagis Ltd | Thiocarboxylic acid organic salts and processes utilizing the same |
| EP2402360B1 (en) * | 2006-06-14 | 2020-04-01 | Generics [UK] Limited | Process for the preparation of S-fluoromethyl-6,9-difluoro-11-hydroxy-16-methyl-17-propionyloxy-3-oxo-androsta-1,4-diene-17-carbothioate and intermediates |
| AU2013202843B2 (en) * | 2006-06-14 | 2015-11-12 | Generics [Uk] Limited | Process for the preparation of S-fluoromethyl-6,9-difluoro-11-hydroxy-16-methyl-17-propionyloxy-3-oxo-androsta-1, 4-diene-17-carbothioate and intermediates |
| EP2611821A2 (en) * | 2010-09-01 | 2013-07-10 | Cadila Healthcare Limited | Process for preparing fluticasone propionate/furoate |
| US10370402B2 (en) * | 2011-07-08 | 2019-08-06 | Pfizer Limited | Process for the preparation of fluticasone propionate form 1 |
| MX361886B (es) | 2012-05-08 | 2018-12-18 | Nicox Ophthalmics Inc | Preparaciones de agentes terapéuticos hidrófobos, métodos de elaboración y uso de los mismos. |
| US8765725B2 (en) | 2012-05-08 | 2014-07-01 | Aciex Therapeutics, Inc. | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
| DE102012221219B4 (de) * | 2012-11-20 | 2014-05-28 | Jesalis Pharma Gmbh | Verfahren zur Vergrößerung der Partikelgröße kristalliner Wirkstoff-Mikropartikel |
| US9815865B2 (en) | 2013-01-07 | 2017-11-14 | Nicox Ophthalmics, Inc. | Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2455976A1 (de) * | 1974-11-27 | 1976-08-12 | Merck Patent Gmbh | Prostensaeurederivate |
| JPS56138200A (en) * | 1980-02-15 | 1981-10-28 | Glaxo Group Ltd | Androstane carbothioate compound |
| US5783677A (en) * | 1993-09-24 | 1998-07-21 | Procter & Gamble Pharmaceuticals, Inc. | Deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds |
| US5488188A (en) * | 1994-09-29 | 1996-01-30 | Merrell Dow Pharmaceuticals Inc. | Process for the preparation of (E)-1-amino-2-(fluoromethylene)-4-(p-fluorophenyl)butane, novel processes for preparing an intermediate thereof, and novel intermediates thereof |
| GB9622173D0 (en) * | 1996-10-24 | 1996-12-18 | Glaxo Group Ltd | Particulate Products |
| GB9925934D0 (en) * | 1999-11-03 | 1999-12-29 | Glaxo Group Ltd | Novel apparatus and process |
| IL154175A0 (en) * | 2000-08-05 | 2003-07-31 | Glaxo Group Ltd | 17. beta.-carbothioate 17. alpha-arylcarbonyloxyloxy androstane derivatives as anti-inflammatory agents |
-
2002
- 2002-02-04 GB GBGB0202564.1A patent/GB0202564D0/en not_active Ceased
-
2003
- 2003-01-30 TW TW092102249A patent/TW200410982A/zh unknown
- 2003-01-31 AR ARP030100299A patent/AR038390A1/es not_active Application Discontinuation
- 2003-02-03 BR BR0307243-6A patent/BR0307243A/pt not_active IP Right Cessation
- 2003-02-03 DE DE60329824T patent/DE60329824D1/de not_active Expired - Fee Related
- 2003-02-03 NZ NZ534320A patent/NZ534320A/en unknown
- 2003-02-03 AT AT03704541T patent/ATE446965T1/de not_active IP Right Cessation
- 2003-02-03 WO PCT/EP2003/001115 patent/WO2003066653A2/en active Application Filing
- 2003-02-03 US US10/502,866 patent/US20050222107A1/en not_active Abandoned
- 2003-02-03 JP JP2003566024A patent/JP2005517019A/ja active Pending
- 2003-02-03 CN CNB038074370A patent/CN100338087C/zh not_active Expired - Fee Related
- 2003-02-03 AU AU2003206836A patent/AU2003206836B2/en not_active Ceased
- 2003-02-03 EP EP03704541A patent/EP1474436B1/en not_active Expired - Lifetime
- 2003-02-03 KR KR10-2004-7011981A patent/KR20040086331A/ko not_active Application Discontinuation
- 2003-02-03 CA CA002473896A patent/CA2473896A1/en not_active Abandoned
- 2003-02-03 MX MXPA04007530A patent/MXPA04007530A/es active IP Right Grant
- 2003-02-03 PL PL03372214A patent/PL372214A1/xx unknown
- 2003-02-03 RU RU2004122928/04A patent/RU2333218C2/ru not_active IP Right Cessation
-
2004
- 2004-07-21 ZA ZA200405826A patent/ZA200405826B/en unknown
- 2004-07-26 IS IS7373A patent/IS7373A/is unknown
- 2004-07-30 CO CO04074014A patent/CO5611115A2/es not_active Application Discontinuation
- 2004-09-01 NO NO20043664A patent/NO327138B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| GB0202564D0 (en) | 2002-03-20 |
| DE60329824D1 (de) | 2009-12-10 |
| CO5611115A2 (es) | 2006-02-28 |
| PL372214A1 (en) | 2005-07-11 |
| TW200410982A (en) | 2004-07-01 |
| EP1474436A2 (en) | 2004-11-10 |
| WO2003066653A3 (en) | 2003-12-24 |
| KR20040086331A (ko) | 2004-10-08 |
| AU2003206836A1 (en) | 2003-09-02 |
| CA2473896A1 (en) | 2003-08-14 |
| ZA200405826B (en) | 2005-08-11 |
| US20050222107A1 (en) | 2005-10-06 |
| ATE446965T1 (de) | 2009-11-15 |
| AU2003206836B2 (en) | 2009-01-08 |
| CN100338087C (zh) | 2007-09-19 |
| CN1642969A (zh) | 2005-07-20 |
| RU2004122928A (ru) | 2005-05-27 |
| RU2333218C2 (ru) | 2008-09-10 |
| JP2005517019A (ja) | 2005-06-09 |
| NO327138B1 (no) | 2009-05-04 |
| NO20043664L (no) | 2004-09-01 |
| MXPA04007530A (es) | 2004-11-10 |
| IS7373A (is) | 2004-07-26 |
| NZ534320A (en) | 2007-07-27 |
| EP1474436B1 (en) | 2009-10-28 |
| BR0307243A (pt) | 2004-12-14 |
| WO2003066653A2 (en) | 2003-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021505614A5 (es) | ||
| AR038390A1 (es) | Proceso para preparar propionato de fluticasona. | |
| AR035992A1 (es) | Proceso para producir acido tereftalico puro con recuperacion mejorada de precursores, solvente y metil acetato | |
| JP2011126894A5 (es) | ||
| ES2567081T3 (es) | Producción continua de sales cuaternarias | |
| MX173525B (es) | Mejoras en un procedimiento para la preparacion de 6-metil-3,4-dihidro-1,2,3-oxatiazin-4-ona-2,2-dioxido por cierre de anillo de un derivado de acetoacetamida | |
| AR063415A1 (es) | Hidratos de clorhidrato de erlotinib para el tratamiento del cancer | |
| CN103788069B (zh) | 埃索美拉唑镁三水合物的制备方法 | |
| CN106986800B (zh) | 一种β-羰基硫醚的制备方法 | |
| IL195622A0 (en) | Process for the purification of montelukast | |
| ATE266020T1 (de) | Synthese von r-(+)-alpha-liponsäure | |
| HRP20170497T1 (hr) | Postupak dobivanja nalmefen hidroklorida | |
| BRPI0615131A2 (pt) | preparação de tioalquilaminas com rendimentos elevados | |
| CN102887853A (zh) | 一种群多普利中间体的制备方法 | |
| CN104311459A (zh) | 一种氧化不对称硫醚制备亚砜的方法 | |
| CN102757367A (zh) | 一种混旋苯乙磺酸的拆分工艺 | |
| CN104311458A (zh) | 氧化对称硫醚制备亚砜的方法 | |
| CN103351311A (zh) | 一种二苯乙腈的合成方法 | |
| AR014939A1 (es) | Proceso para purificar una solucion de un ester profarmaco de ampicilina | |
| CN104292222A (zh) | 一种替比培南匹伏酯侧链的新的合成方法 | |
| SU502875A1 (ru) | Способ получени метилового эфира 4-диметиламиносалициловой кислоты | |
| DE60127455D1 (de) | Verfahren zur herstellung von beta-ketonitrilverbindungen | |
| CN105646396A (zh) | 一种苯并噻唑衍生物的合成方法 | |
| NZ627247A (en) | Synthesis of calebin-a and its biologically active analogs | |
| CN103965130B (zh) | 一种帕立骨化醇中间体的制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |